Akero Histology Data Could Be Best In Class For NASH

 
• By Joseph Haas
  
Female person holding red human liver model at white body
Akero's FGF21 analog may offer antifibrotic and NASH-resolution benefits
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D